Boothbay Fund Management’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $796K | Sell |
293,565
-18,593
| -6% | -$50.4K | 0.02% | 596 |
|
|
2025
Q1 | $1.06M | Sell |
312,158
-29,765
| -9% | -$101K | 0.03% | 483 |
|
|
2024
Q4 | $1.41M | Buy |
+341,923
| New | +$1.41M | 0.03% | 448 |
|
|
2023
Q3 | – | Sell |
-22,050
| Closed | -$30.2K | – | 1595 |
|
|
2023
Q2 | $30.2K | Hold |
22,050
| – | – | ﹤0.01% | 1477 |
|
|
2023
Q1 | $52K | Hold |
22,050
| – | – | ﹤0.01% | 1764 |
|
|
2022
Q4 | $50.3K | Hold |
22,050
| – | – | ﹤0.01% | 1629 |
|
|
2022
Q3 | $61K | Sell |
22,050
-12,580
| -36% | -$34.8K | ﹤0.01% | 1810 |
|
|
2022
Q2 | $85K | Hold |
34,630
| – | – | ﹤0.01% | 1742 |
|
|
2022
Q1 | $136K | Hold |
34,630
| – | – | ﹤0.01% | 1639 |
|
|
2021
Q4 | $153K | Hold |
34,630
| – | – | ﹤0.01% | 1419 |
|
|
2021
Q3 | $214K | Sell |
34,630
-5,422
| -14% | -$33.5K | 0.01% | 1293 |
|
|
2021
Q2 | $317K | Buy |
40,052
+11,360
| +40% | +$89.9K | 0.01% | 1089 |
|
|
2021
Q1 | $307K | Buy |
+28,692
| New | +$307K | 0.01% | 967 |
|